MARKET

IRWD

IRWD

Ironwood
NASDAQ
9.24
-0.39
-4.05%
After Hours: 9.44 +0.2 +2.16% 19:38 10/02 EDT
OPEN
9.63
PREV CLOSE
9.63
HIGH
9.69
LOW
9.10
VOLUME
3.20M
TURNOVER
0
52 WEEK HIGH
12.66
52 WEEK LOW
8.08
MARKET CAP
1.44B
P/E (TTM)
-1.5304
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at IRWD last week (0925-0929)?
Weekly Report · 14h ago
JMP starts Ironwood at market outperform, cites potential of GLP-2 drug
Seeking Alpha · 4d ago
JMP Securities Initiates Coverage of Ironwood Pharmaceuticals Inc - (IRWD) with Market Outperform Recommendation
NASDAQ · 4d ago
Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023
Benzinga · 4d ago
JMP Securities Initiates Coverage On Ironwood Pharmaceuticals with Market Outperform Rating, Announces Price Target of $22
Benzinga · 4d ago
Analysts Offer Insights on Healthcare Companies: Mirati Therapeutics (MRTX) and Ironwood Pharma (IRWD)
TipRanks · 4d ago
Analysts Anticipate SLYG Will Reach $91
NASDAQ · 09/25 14:28
Weekly Report: what happened at IRWD last week (0918-0922)?
Weekly Report · 09/25 09:15
More
About IRWD
Ironwood Pharmaceuticals, Inc. is a gastrointestinal (GI) healthcare company, which is advancing the treatment of GI diseases and redefining the standard of care for GI patients. It develops and commercializes GI product opportunities in areas of significant unmet need, leveraging its demonstrated expertise and capabilities in GI diseases. LINZESS (linaclotide), its commercial product, in a class of GI medicines called guanylate cyclase type C agonists (GC-C agonists) and is indicated for adult men and women suffering from irritable bowel syndrome with constipation (IBS-C), or chronic idiopathic constipation (CIC). LINZESS is available to adult men and women suffering from IBS-C or CIC in the United States and Mexico, IBS-C or chronic constipation in Japan, and IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA to adult men and women suffering from IBS-C or CIC in Canada, and to adult men and women suffering from IBS-C in certain European countries.

Webull offers kinds of Ironwood Pharmaceuticals, Inc. stock information, including NASDAQ:IRWD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IRWD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading IRWD stock methods without spending real money on the virtual paper trading platform.